We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$13B
AUM Growth
+$1.56B
Cap. Flow
+$847M
Cap. Flow %
6.54%
Top 10 Hldgs %
18.23%
Holding
2,527
New
188
Increased
1,360
Reduced
792
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 6.93%
2 Financials 4.91%
3 Healthcare 4.18%
4 Consumer Discretionary 3.53%
5 Communication Services 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCTR icon
901
First Trust Lunt US Factor Rotation ETF
FCTR
$56.9M
$1.58M 0.01%
69,552
-2,685
-4% -$59.5K
DLR icon
902
Digital Realty Trust
DLR
$73.1B
$1.58M 0.01%
13,208
+1,914
+17% +$236K
SRVR icon
903
Pacer Data & Infrastructure Real Estate ETF
SRVR
$389M
$1.58M 0.01%
48,455
+27,491
+131% +$868K
IEUR icon
904
iShares Core MSCI Europe ETF
IEUR
$9.15B
$1.57M 0.01%
31,575
-172
-0.5% -$8.2K
DWX icon
905
State Street SPDR S&P International Dividend ETF
DWX
$529M
$1.57M 0.01%
39,154
-2,584
-6% -$103K
VIOG icon
906
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.13B
$1.57M 0.01%
18,994
-2,490
-12% -$197K
NULV icon
907
Nuveen ESG Large-Cap Value ETF
NULV
$2.29B
$1.57M 0.01%
47,934
+20,765
+76% +$664K
TDY icon
908
Teledyne Technologies
TDY
$31.2B
$1.57M 0.01%
4,535
-1,138
-20% -$383K
BSCO
909
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
$1.57M 0.01%
73,046
+23,199
+47% +$497K
FITB
910
Fifth Third Bancorp
FITB
$52.5B
$1.56M 0.01%
50,844
+1,437
+3% +$42.1K
MRSH
911
Marsh
MRSH
$90B
$1.56M 0.01%
14,027
-2,634
-16% -$275K
TEVA icon
912
Teva Pharmaceuticals
TEVA
$42.6B
$1.56M 0.01%
159,139
+127,245
+399% +$1.14M
PARA
913
DELISTED
Paramount Global Class B
PARA
$1.56M 0.01%
37,142
+19,736
+113% +$764K
WTRE icon
914
WisdomTree New Economy Real Estate Fund
WTRE
$16.1M
$1.56M 0.01%
49,716
+2,838
+6% +$86.4K
ETR icon
915
Entergy
ETR
$49.9B
$1.56M 0.01%
25,998
-32,754
-56% -$1.93M
BSX icon
916
Boston Scientific
BSX
$74.9B
$1.55M 0.01%
34,248
+658
+2% +$27.5K
EMN icon
917
Eastman Chemical
EMN
$8.43B
$1.54M 0.01%
19,465
+2,649
+16% +$204K
VGR
918
DELISTED
Vector Group Ltd.
VGR
$1.54M 0.01%
162,457
+1,845
+1% +$16.1K
FXR icon
919
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$771M
$1.54M 0.01%
34,068
+28,046
+466% +$1.22M
STXB
920
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
$1.54M 0.01%
66,761
HE icon
921
Hawaiian Electric Industries
HE
$2.04B
$1.53M 0.01%
32,766
-24
-0.1% -$1.07K
JBHT icon
922
JB Hunt Transport Services
JBHT
$26.5B
$1.53M 0.01%
13,140
-1,275
-9% -$146K
KEY icon
923
KeyCorp
KEY
$24.6B
$1.53M 0.01%
75,676
+6,424
+9% +$121K
FLQL icon
924
Franklin US Large Cap Multifactor Index ETF
FLQL
$2.12B
$1.53M 0.01%
43,748
+24,029
+122% +$813K
NULG icon
925
Nuveen ESG Large-Cap Growth ETF
NULG
$2.81B
$1.53M 0.01%
36,918
+16,674
+82% +$662K

Similar funds

Cambridge Investment Research Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Cambridge Investment Research Advisors held 2,527 positions worth $13B, up 14% from $11.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cambridge Investment Research Advisors deployed $847M of net new capital in Q4 2019, opening 188 new positions and adding to 1,360 existing holdings. Its largest new stake was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 76,384 shares worth $5.5M.

By sector, the portfolio is most concentrated in Technology at 6.9% of assets, up from 6.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $23.2M trimmed.

  • Cambridge Investment Research Advisors's largest Q4 2019 buy was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 76,384 shares worth $5.5M.
  • Cambridge Investment Research Advisors added most to Vanguard Morningstar Total Stock Market ETF in Q4 2019, an estimated $38.2M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2019 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $23.2M.
  • Cambridge Investment Research Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $13.9M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $13B portfolio in Q4 2019.
  • Cambridge Investment Research Advisors opened 188 new positions and closed 124 in Q4 2019.
  • Cambridge Investment Research Advisors's portfolio value rose 14% quarter-over-quarter to $13B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2019, filed 4 Feb 2020.